APA

Engert A., Diehl V., Schnell R., Radszuhn A., Hatwig M. T., Drillich S., Schön G., Bohlen H., Tesch H., Hansmann M. L., Barth S., Schindler J., Ghetie V., Uhr J. & Vitetta E. (19970224). A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. : Blood.

Chicago

Engert A, Diehl V, Schnell R, Radszuhn A, Hatwig M T, Drillich S, Schön G, Bohlen H, Tesch H, Hansmann M L, Barth S, Schindler J, Ghetie V, Uhr J and Vitetta E. 19970224. A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. : Blood.

Harvard

Engert A., Diehl V., Schnell R., Radszuhn A., Hatwig M. T., Drillich S., Schön G., Bohlen H., Tesch H., Hansmann M. L., Barth S., Schindler J., Ghetie V., Uhr J. and Vitetta E. (19970224). A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. : Blood.

MLA

Engert A, Diehl V, Schnell R, Radszuhn A, Hatwig M T, Drillich S, Schön G, Bohlen H, Tesch H, Hansmann M L, Barth S, Schindler J, Ghetie V, Uhr J and Vitetta E. A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. : Blood. 19970224.